GSK seeks European approval for chlorhexidine gel to prevent umbilical cord infections in newborns

GlaxoSmithKline (GSK) has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval for its antiseptic chlorhexidine gel to prevent umbilical cord infections (omphalitis) in newborn babies.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news